First Implantation of RayOne Aspheric Fully Preloaded IOL in United States Completed by Renowned Surgeon William F. Wiley, MD
Posted on 6/02/2019
NEW YORK, New York, February 01, 2019 – The first U.S. implantation of Rayner’s flagship RayOne Aspheric fully preloaded monofocal IOL (RAO600C) was successfully performed by William F. Wiley, MD at the Brecksville Surgery Center in Cleveland, Ohio following FDA approval in late 2018.
After the surgery, Dr. Wiley commented that “RayOne Aspheric is a game changer. After trying multiple preloaded systems, this is the easiest and simplest preloaded system on the market, coupled with the ability to go through the smallest incision.”
Rayner’s Director of North America, James Crutchlow, said “we are excited about this first U.S. implantation of RayOne Aspheric and very grateful for Dr Wiley’s participation. We look forward to continuing to build our presence in the United States and providing surgeons with this latest innovation in injector technology.”
What sets RayOne Aspheric apart
The RayOne Aspheric fully preloaded injector delivers the IOL consistently with expert control, all through a micro incision with minimal wound stretch. RayOne Aspheric includes patented Lock & Roll technology for the smallest fully preloaded IOL incision. Benefits include:
- Easy to use, 2-step system
- Enhanced 6.0 mm aspheric optic
- 1.65 mm nozzle diameter for sub-2.2 mm delivery
Available from February 2019
RayOne Aspheric will be available to surgeons from all Rayner commercial consultants across the United States in a large power range of +8.0 D to +34.0 D, from February 2019.
To learn more about the FDA approval of RayOne Aspheric, visit https://usa.rayner.com/rayone-aspheric-now-available-in-usa/
To learn more about RayOne Aspheric, visit https://usa.rayner.com/usa/iols/monofocal/rayoneaspheric/
Rayner is a leading developer and manufacturer of ophthalmic implants and pharmaceuticals, focused on providing the best visual outcomes for clinicians and patients and driven by science to improve performance and safety. When Sir Harold Ridley designed the world’s first IOL in 1949, he chose Rayner to manufacture this ground-breaking invention and with more than 70 years of continuous growth and experience, we remain at the forefront of ophthalmic innovation.
Headquartered in Worthing, United Kingdom, Rayner markets its IOL portfolio and related products worldwide in over 80 countries through a network of distributors and direct sales teams in the United Kingdom, USA, Germany & Austria, Italy, Spain and Portugal.
For general enquiries or to arrange an interview, please contact Rayner: email@example.com
Not all Rayner products are approved for sale in every country. Please contact your local Rayner distributor for details of which products are available in your area.